Funding will support development of innovative nail fungus treatment technology.
- ArrayPatch has closed a $3 million seed funding round.
- The funding aims to advance the ITZ Dermap treatment technology.
- ITZ Dermap targets nail fungus with a unique therapeutic approach.
ArrayPatch has recently announced the completion of the first close of a $3 million seed funding round. This financing will aid in the advancement of ITZ Dermap, an innovative technology specifically for the treatment of nail fungus. This development is a key step in the company's ongoing efforts to provide effective solutions in dermatology and address common health issues.
The funding will enable ArrayPatch to further develop its ITZ Dermap platform, which is designed to tackle nail fungus more effectively. By focusing on this prevalent condition, the company aims to improve patient outcomes through its cutting-edge therapeutic approach. The seed funding reflects growing interest in innovative health technologies and the need for new treatment options in dermatological care.
